Goals and Objectives
Introduction
Applying Lipid Clinical Trials to the Practical Management of High-Risk Patients
Integrating Risk Factor Management into the Care of the Cardiac Patient
Risk-Factor Management in Women and Other Special Patients
Clinical Implications of Recent Cholesterol Lowering Trials for the Secondary Prevention of Coronary Heart Disease
Risk Factor Management: Exploring the Boundaries
CME Quiz
Bibliography
Converting Clinical Lipid Trials into the Practical Management of High-Risk Patients: New NECP Thoughts on Treating CHD Patients
Review of the NIH Post-CABG Study and Future Advances in HMG-CoA Therapy
Accuracy of Lipid Profiles in the Hospital Setting: Impact on the Initiation of Cholesterol-Lowering Therapy
The Undertreatment Problem: Identifying Barriers to Treatment
Practical Disease Management as a Solution to the Undertreatment Problem
Impact of Risk Factor Modification on the CHD Process
Major Clinical Trials: Pharmacologic Therapy in Higher Risk Patients
Lack of Intensive Treatment of CHD Risk Factors: Could the Physician Be the Most Important Risk Factor?
Risk Factor Management and the Interventionalist: Treating the Patient, Not Just the Lesion
The Role of the Nurse Case Manager
The Role of the Managed Care Industry
Lessons Learned from Lipid-Lowering Trials That Have Included Women
Identifying Women at Risk and Providing Protective Measures
What Do Recent Trials Tell Us About Statins?
Strategies to Enhance Risk Factor Management in Clinical Practice
Safety and Tolerability of Lipid-Lowering Drugs After Heart Transplantation: The Heart Transplant Lipid Registry
Possible Use of Ultrafast CT of Coronaries to Make Decisions in Hyperlipidemic Patients
Treatment of Combined Hyperlipidemia: Whether and How
Participants
